Genmab A (GMAB) Divestments (2018 - 2026)

Genmab A (GMAB) has reported Divestments for 9 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Divestments rose 400.0% year-over-year to $9.0 million; the trailing twelve-month figure through Jun 2026 stood at -$1.0 million (up 94.12% YoY), and the FY2025 full-year result was -$4.0 million, up 50.0% from the prior year.
• Divestments improved to $9.0 million in Q2 2026 per GMAB's latest filing, from -$4.0 million in the prior quarter.
• Across five years, Divestments topped out at $241.3 million in Q4 2022 and bottomed at -$131.3 million in Q3 2022.
• Historically, Divestments has averaged $11.6 million across 5 years, with a median of -$3.0 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Divestments sank 2528.53% in 2024, then jumped 400.0% in 2026.
• Over 5 years, Divestments stood at $241.3 million in 2022, then tumbled by 101.66% to -$4.0 million in 2023, then tumbled by 100.0% to -$8.0 million in 2024, then soared by 62.5% to -$3.0 million in 2025, then surged by 400.0% to $9.0 million in 2026.
• According to Business Quant data, Divestments over the past three periods registered $9.0 million, -$4.0 million, and -$3.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.